IRIS
Gennari, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.955
NA - Nord America 1.908
AS - Asia 497
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 5
AF - Africa 2
Totale 5.375
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.890
IE - Irlanda 1.037
IT - Italia 761
DE - Germania 380
SE - Svezia 367
UA - Ucraina 294
CN - Cina 162
HK - Hong Kong 121
VN - Vietnam 116
IN - India 56
GB - Regno Unito 42
FR - Francia 34
IR - Iran 24
CA - Canada 18
FI - Finlandia 15
BE - Belgio 10
EU - Europa 8
TR - Turchia 7
SG - Singapore 4
MK - Macedonia 3
PH - Filippine 3
AT - Austria 2
BR - Brasile 2
CH - Svizzera 2
ES - Italia 2
JP - Giappone 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
RU - Federazione Russa 2
SY - Repubblica araba siriana 2
CL - Cile 1
EG - Egitto 1
UG - Uganda 1
Totale 5.375
Salva come PNG Salva come JPEG
Città #
Dublin 1.032
Jacksonville 597
Piemonte 373
Dearborn 230
Lawrence 129
Princeton 129
Wilmington 125
Hong Kong 120
Dong Ket 116
Chandler 96
Beijing 79
Ashburn 48
Bremen 47
Ann Arbor 46
San Mateo 44
Milan 25
Houston 16
Novara 16
Turin 16
Helsinki 15
Toronto 15
Nanjing 14
Rome 14
Andover 13
Norwalk 13
Strasbourg 13
Monmouth Junction 12
Brussels 10
Fairfield 10
Hefei 10
Kunming 10
Odalengo Grande 9
Zanjan 9
Ardabil 8
Grafing 8
North Ridgeville 8
Naples 7
Redwood City 7
Fuzhou 6
Nardò 6
Torino 6
Woodbridge 6
Kocaeli 5
Leawood 5
Pavia 5
Sacramento 5
Shenyang 5
Alessandria 4
Augusta 4
Avezzano 4
Bologna 4
Cambridge 4
Chatteris 4
Dallas 4
Guangzhou 4
Jinan 4
New York 4
Palermo 4
Paris 4
Saint-Fons 4
West Jordan 4
Alba 3
Boardman 3
Cassano Magnago 3
Castelnuovo Bormida 3
Catanzaro 3
Faenza 3
Gunzenhausen 3
Hebei 3
Pioltello 3
Seattle 3
Stradella 3
Verona 3
Ankara 2
Appiano Gentile 2
Bagnoli del Trigno 2
Berlin 2
Boadilla del Monte 2
Bucharest 2
Bulandshahr 2
Busalla 2
Caloocan City 2
Francavilla Fontana 2
Giugliano In Campania 2
Henderson 2
Legnano 2
Lima 2
Montréal 2
Mülheim 2
Nanning 2
Philadelphia 2
Polistena 2
Pune 2
Romainville 2
San Diego 2
Santa Maria a Vico 2
Senago 2
Shanghai 2
Shaoxing 2
Skopje 2
Totale 3.684
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 137
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 94
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 93
Insulin-like Growth Factor-1 Receptor (IGF-1R) expression on Circulating Tumor Cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial 88
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 87
Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights 68
Bone health, vitamin D status and oral hygiene screening in breast cancer women before starting osteoporosis treatment: a cross-sectional study 64
Curative Lung Metastasectomy Without Concomitant Androgen Deprivation Therapy in Oligometastatic Castration-resistant Prostate Cancer: A Case Report and Review of the Literature 63
Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer 61
A randomized phase II study evaluating different maintenance schedules of nab-Paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial 59
3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). 59
3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) 58
ERA-Net TRANSCAN JTC 2011: Critical aspects of the startup procedures of an International Academic Clinical trial (ET-FES), funded by the European Community (EC) and coordinated by an Italian Institution 58
Anthracycline-free therapy for HER2-amplified breast cancer 56
Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial 56
Breast Cancer Survivorship, Quality of Life and Late Toxicities 56
Adjuvant chemotherapy in breast cancer. International perspective 55
Metastatic mediastinal germ-cell tumor and concurrent COVID-19: when chemotherapy is not deferrable. 55
The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it. 54
Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer 53
Axillary web syndrome in women after breast cancer surgery referred to an Oncological Rehabilitation Unit: which are the main risk factors? A retrospective case-control study 53
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 53
Anthracyclines in the management of metastatic breast cancer: state of the art 52
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial 52
Implications of metabolism-driven myeloid dysfunctions in cancer therapy 52
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy 51
Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey 51
HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support 50
Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progression. 50
Identification of a prognostic signature based on the expression of genes related to the insulin pathway in early breast cancer 50
Oncolytic virotherapy: new weapon for breast cancer treatment 50
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT 49
Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapy 49
Aging and endothelial function in normotensive subjects and patients with essential hypertension 48
Early Assessment by PET with FDG of Response to First-Line Chemotherapy of Metastatic Breast Cancer 48
Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study 48
Apalutamide, darolutamide and enzalutamide for nonmetastatic castration-resistant prostate cancer (nmCRPC) 48
Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer. 47
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 47
Dual block with lapatinib and trastuzumab versus single agent trastuzumab combined with chemotherapy as neoadjuvant treatment of HER2-positive breast cancer: a meta-analysis of randomized trials 46
[Management of nausea and vomiting in cancer patients. Use of transdermal patches containing granisetron in patients affected by head and neck squamous-cell carcinoma] 46
Anthracyclines-paclitaxel combinations in the treatment of breast cancer 45
Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer 45
Bevacizumab and breast cancer: A meta-analysis of first-line phase III studies and a critical reappraisal of available evidence 45
Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of patients with cancer who recovered from SARS-Cov-2 infection: results from the OnCovid registry. 45
Why are guidelines not followed in clinical practice? 44
Cardiotoxicity of other Anthracycline Analogues 44
An observational study of nasal cavity toxicity in cancer patients treated with bevacizumab 44
Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer 43
Impact of Body Mass Index (BMI) on the prognosis of high risk early breast cancer (EBC) patients treated with adjuvant chemotherapy 43
Age influence on some aspects of cardiovascular adaptation to hypertension 43
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: The OnCovid Inflammatory Score 43
Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients 42
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer 42
Extending the duration of first-line chemotherapy in metastatic breast cancer: A perspective review 42
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study 42
Short- and long-term reproducibility of techniques employed to assess sympathetic tone in humans: a preliminary report 41
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 41
New combinations with epirubicin in advanced breast cancer 40
The quality of life issue in metastatic breast cancer 40
Survival of metastatic breast carcinoma patients over a 20-year period - A retrospective analysis based on individual patient data from six consecutive studies 40
Identification and validation of a new set of five genes for prediction of risk in early breast cancer 40
Cancer and fertility preservation: international recommendations from an expert meeting 40
Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies 40
Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic review 40
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE). 40
Cardiotossicità da antracicline 40
Three-dimensional laser scanning as a reliable and reproducible diagnostic tool in breast cancer related lymphedema rehabilitation: a proof-of-principle study 40
SARS-CoV-2 re-infection in a cancer patient with a defective neutralizing humoral response 40
Precision Medicine in Systemic Mastocytosis 40
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: Role of cardiac risk factors 39
Paclitaxel plus epirubicin in advanced breast cancer 39
Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancer 39
Gestione di nausea e vomito nel paziente oncologico. Utilizzo di cerotti transdermici contenenti granisetron in paziente affetto da neoplasia del distretto cervico-cefalico 39
Duration of Chemotherapy for Metastatic Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 38
New Understanding of the Role of Anthracyclines in Early-Stage Breast Cancer: Patient Selection Considerations 38
Insulin breast cancer connection: confirmatory data set the stage for better care. 38
Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxel 38
A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer 38
Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer 37
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis 37
Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial 37
Oral chemotherapy in advanced breast cancer: expert perspectives on its role in clinical practice 37
Case histories: breast cancer 36
Epirubicin/taxane combinations in breast cancer: Experience from several Italian trials 36
Whither the PET Scan? The Role of PET Imaging in the Staging and Treatment of Breast Cancer 36
Exemestane for Breast Cancer Prevention: A Critical Shift? 36
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study 35
Microinjections of alpha 1- and alpha 2-noradrenergic substances in the cerebellar vermis of decerebrate cats affect the gain of the vestibulospinal reflexes 35
Breast Cancer Diet "BCD": A Review of Healthy Dietary Patterns to Prevent Breast Cancer Recurrence and Reduce Mortality 35
Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer 34
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study 34
Pemetrexed: A promising new treatment for breast cancer 34
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer 34
The gemcitabine/epirubicin/paclitaxel combination in advanced breast cancer 33
Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients 33
Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients 33
Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: A regimen with high activity and low cardiotoxicity in advanced breast cancer 33
Gemcitabine, epirubicin and paclitaxel: pharmacokinetlic and pharmacodynamic interactions in advanced breast cancer 32
Role of epirubicin in advanced breast cancer 32
Totale 4.703
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.248
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.248
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.071 3 0 111 12 144 156 199 56 117 167 104 2
2020/2021946 117 3 108 7 122 34 136 16 130 19 122 132
2021/2022892 65 23 84 107 29 33 60 32 92 60 135 172
2022/20231.814 162 69 132 18 69 138 54 75 992 21 45 39
2023/2024521 90 29 53 26 128 17 126 17 19 13 3 0
Totale 5.706